160 related articles for article (PubMed ID: 26564800)
21. Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer.
Macoska JA; Trybus TM; Benson PD; Sakr WA; Grignon DJ; Wojno KD; Pietruk T; Powell IJ
Cancer Res; 1995 Nov; 55(22):5390-5. PubMed ID: 7585607
[TBL] [Abstract][Full Text] [Related]
22. [Significance of MMP2 and MMP9 expression in prostate cancer].
Zhang XY; Hong BF; Chen GF; Lu YL; Zhong M
Zhonghua Nan Ke Xue; 2005 May; 11(5):359-61, 364. PubMed ID: 15934460
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide methylation analysis identifies involvement of TNF-α mediated cancer pathways in prostate cancer.
Kim SJ; Kelly WK; Fu A; Haines K; Hoffman A; Zheng T; Zhu Y
Cancer Lett; 2011 Mar; 302(1):47-53. PubMed ID: 21237555
[TBL] [Abstract][Full Text] [Related]
24. The non-random repositioning of whole chromosomes and individual gene loci in interphase nuclei and its relevance in disease, infection, aging, and cancer.
Bridger JM; Arican-Gotkas HD; Foster HA; Godwin LS; Harvey A; Kill IR; Knight M; Mehta IS; Ahmed MH
Adv Exp Med Biol; 2014; 773():263-79. PubMed ID: 24563352
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide scan of brothers: replication and fine mapping of prostate cancer susceptibility and aggressiveness loci.
Witte JS; Suarez BK; Thiel B; Lin J; Yu A; Banerjee TK; Burmester JK; Casey G; Catalona WJ
Prostate; 2003 Dec; 57(4):298-308. PubMed ID: 14601026
[TBL] [Abstract][Full Text] [Related]
26. Evidence for a prostate cancer susceptibility locus on the X chromosome.
Xu J; Meyers D; Freije D; Isaacs S; Wiley K; Nusskern D; Ewing C; Wilkens E; Bujnovszky P; Bova GS; Walsh P; Isaacs W; Schleutker J; Matikainen M; Tammela T; Visakorpi T; Kallioniemi OP; Berry R; Schaid D; French A; McDonnell S; Schroeder J; Blute M; Thibodeau S; Grönberg H; Emanuelsson M; Damber JE; Bergh A; Jonsson BA; Smith J; Bailey-Wilson J; Carpten J; Stephan D; Gillanders E; Amundson I; Kainu T; Freas-Lutz D; Baffoe-Bonnie A; Van Aucken A; Sood R; Collins F; Brownstein M; Trent J
Nat Genet; 1998 Oct; 20(2):175-9. PubMed ID: 9771711
[TBL] [Abstract][Full Text] [Related]
27. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.
Bova GS; Carter BS; Bussemakers MJ; Emi M; Fujiwara Y; Kyprianou N; Jacobs SC; Robinson JC; Epstein JI; Walsh PC
Cancer Res; 1993 Sep; 53(17):3869-73. PubMed ID: 7689419
[TBL] [Abstract][Full Text] [Related]
28. Involvement of the RNAse L gene in prostate cancer.
Kieffer N; Schmitz M; Scheiden R; Nathan M; Faber JC
Bull Soc Sci Med Grand Duche Luxemb; 2006; (1):21-8. PubMed ID: 16869093
[TBL] [Abstract][Full Text] [Related]
29. Integrative Analysis of Normal Long Intergenic Non-Coding RNAs in Prostate Cancer.
Bawa P; Zackaria S; Verma M; Gupta S; Srivatsan R; Chaudhary B; Srinivasan S
PLoS One; 2015; 10(5):e0122143. PubMed ID: 25933431
[TBL] [Abstract][Full Text] [Related]
30. Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer.
Partin AW; Getzenberg RH; CarMichael MJ; Vindivich D; Yoo J; Epstein JI; Coffey DS
Cancer Res; 1993 Feb; 53(4):744-6. PubMed ID: 7679049
[TBL] [Abstract][Full Text] [Related]
31. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
32. Dickkopf-3 regulates prostate epithelial cell acinar morphogenesis and prostate cancer cell invasion by limiting TGF-β-dependent activation of matrix metalloproteases.
Romero D; Al-Shareef Z; Gorroño-Etxebarria I; Atkins S; Turrell F; Chhetri J; Bengoa-Vergniory N; Zenzmaier C; Berger P; Waxman J; Kypta R
Carcinogenesis; 2016 Jan; 37(1):18-29. PubMed ID: 26503968
[TBL] [Abstract][Full Text] [Related]
33. Crude extract of Euphorbia formosana inhibits the migration and invasion of DU145 human prostate cancer cells: The role of matrix metalloproteinase-2/9 inhibition via the MAPK signaling pathway.
Yang JL; Lin JH; Weng SW; Chen JC; Yang JS; Amagaya S; Funayana S; Wood WG; Kuo CL; Chung JG
Mol Med Rep; 2013 May; 7(5):1403-8. PubMed ID: 23525212
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer.
Lee CT; Capodieci P; Osman I; Fazzari M; Ferrara J; Scher HI; Cordon-Cardo C
Clin Cancer Res; 1999 May; 5(5):977-83. PubMed ID: 10353729
[TBL] [Abstract][Full Text] [Related]
35. Assessment of the Utility of Gene Positioning Biomarkers in the Stratification of Prostate Cancers.
Meaburn KJ; Misteli T
Front Genet; 2019; 10():1029. PubMed ID: 31681438
[TBL] [Abstract][Full Text] [Related]
36. Expression mapping at 12p12-13 in advanced prostate carcinoma.
Kibel AS; Huagen J; Guo C; Isaacs WB; Yan Y; Pienta KJ; Goodfellow PJ
Int J Cancer; 2004 May; 109(5):668-72. PubMed ID: 14999772
[TBL] [Abstract][Full Text] [Related]
37. Alterations in the p53 and MDM-2 genes are infrequent in clinically localized, stage B prostate adenocarcinomas.
Ittmann M; Wieczorek R; Heller P; Dave A; Provet J; Krolewski J
Am J Pathol; 1994 Aug; 145(2):287-93. PubMed ID: 8053489
[TBL] [Abstract][Full Text] [Related]
38. Human prostatic acid phosphatase and prostate specific antigen: protein structure, gene organization, and expression in neoplastic and benign tissues.
Li SS
Kaohsiung J Med Sci; 1996 Aug; 12(8):441-7. PubMed ID: 8774111
[TBL] [Abstract][Full Text] [Related]
39. A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus.
Kaushal A; Myers SA; Dong Y; Lai J; Tan OL; Bui LT; Hunt ML; Digby MR; Samaratunga H; Gardiner RA; Clements JA; Hooper JD
Prostate; 2008 Mar; 68(4):381-99. PubMed ID: 18196551
[TBL] [Abstract][Full Text] [Related]
40. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
